{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:04:57Z","timestamp":1768334697572,"version":"3.49.0"},"reference-count":0,"publisher":"Health Affairs Publishing, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.1377\/hlthaff.2023.01627","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T15:51:36Z","timestamp":1704729096000},"page":"5-5","source":"Crossref","is-referenced-by-count":0,"title":["Pharmaceuticals, Opioid Use, Health Spending, And More"],"prefix":"10.1377","volume":"43","author":[{"given":"Alan R.","family":"Weil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"102","container-title":["Health Affairs"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T15:52:02Z","timestamp":1704729122000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2023.01627"}},"subtitle":["Editor-In-Chief Alan R. Weil highlights research articles from the January 2024 issue of Health Affairs"],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"alternative-id":["10.1377\/hlthaff.2023.01627"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.2023.01627","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}